Comera Life Sciences Holdings, Inc.
DelistedCIK 1907685fmd_0AJNRZY3FP5RMT95JKRKEWYGHBManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2020 to Sep 30, 2023, 12 periods
Latest annual · FY2022
Millions- Total revenues
- 1
- Gross profit
- 0
- Operating income
- (12)
- Net income
- (18)
- Free cash flow
- (10)
Latest quarter · Q3 FY2023
Millions- Total revenues
- 0
- Gross profit
- 0
- Operating income
- (2)
- Net income
- (2)
- Free cash flow
- (2)
Comera Life Sciences Holdings, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2022 | FY2021 | Change | Source |
|---|---|---|---|---|
| Revenue | $633,102 | $319,832 | +97.9% | 10-K 2023-03-17 · proof |
| Gross profit | $422,712 | $158,824 | +166.2% | 10-K 2023-03-17 · proof |
| Operating income | -$12 million | -$5.5 million | 10-K 2023-03-17 · proof | |
| Net income | -$18 million | -$5.5 million | 10-K 2023-03-17 · proof | |
| Cash from operating activities | -$9.8 million | -$3.8 million | 10-K 2023-03-17 · proof | |
| Free cash flow | -$9.8 million | -$3.9 million | 10-K 2023-03-17 · proof | |
| Total assets | $3.7 million | $7.4 million | -49.8% | 10-K 2023-03-17 · proof |
| Total liabilities | $5.5 million | $1.2 million | +337.7% | 10-K 2023-03-17 · proof |
| Cash and cash equivalents | $446,607 | $6.5 million | -93.1% | 10-K 2023-03-17 · proof |
- What was Comera Life Sciences Holdings, Inc.'s revenue in fiscal 2022?
- Comera Life Sciences Holdings, Inc. reported revenue of $633,102 for fiscal 2022 (the year ended Dec 31, 2022), against $319,832 the year before (+97.9%). Source: the 10-K filed with the SEC on Mar 17, 2023. SEC
- What was Comera Life Sciences Holdings, Inc.'s gross profit in fiscal 2022?
- Comera Life Sciences Holdings, Inc. reported gross profit of $422,712 for fiscal 2022 (the year ended Dec 31, 2022), against $158,824 the year before (+166.2%). Source: the 10-K filed with the SEC on Mar 17, 2023. SEC
- What was Comera Life Sciences Holdings, Inc.'s operating income in fiscal 2022?
- Comera Life Sciences Holdings, Inc. reported operating income of -$12 million for fiscal 2022 (the year ended Dec 31, 2022), against -$5.5 million the year before. Source: the 10-K filed with the SEC on Mar 17, 2023. SEC
- What was Comera Life Sciences Holdings, Inc.'s net income in fiscal 2022?
- Comera Life Sciences Holdings, Inc. reported net income of -$18 million for fiscal 2022 (the year ended Dec 31, 2022), against -$5.5 million the year before. Source: the 10-K filed with the SEC on Mar 17, 2023. SEC
- What was Comera Life Sciences Holdings, Inc.'s cash from operating activities in fiscal 2022?
- Comera Life Sciences Holdings, Inc. reported cash from operating activities of -$9.8 million for fiscal 2022 (the year ended Dec 31, 2022), against -$3.8 million the year before. Source: the 10-K filed with the SEC on Mar 17, 2023. SEC
- What was Comera Life Sciences Holdings, Inc.'s free cash flow in fiscal 2022?
- Comera Life Sciences Holdings, Inc. reported free cash flow of -$9.8 million for fiscal 2022 (the year ended Dec 31, 2022), against -$3.9 million the year before. Source: the 10-K filed with the SEC on Mar 17, 2023. SEC
- What are Comera Life Sciences Holdings, Inc.'s total assets?
- As of Dec 31, 2022, Comera Life Sciences Holdings, Inc. reported total assets of $3.7 million, against $7.4 million a year earlier (-49.8%). Source: the 10-K filed with the SEC on Mar 17, 2023. SEC
- What are Comera Life Sciences Holdings, Inc.'s total liabilities?
- As of Dec 31, 2022, Comera Life Sciences Holdings, Inc. reported total liabilities of $5.5 million, against $1.2 million a year earlier (+337.7%). Source: the 10-K filed with the SEC on Mar 17, 2023. SEC
- What are Comera Life Sciences Holdings, Inc.'s cash and cash equivalents?
- As of Dec 31, 2022, Comera Life Sciences Holdings, Inc. reported cash and cash equivalents of $446,607, against $6.5 million a year earlier (-93.1%). Source: the 10-K filed with the SEC on Mar 17, 2023. SEC
Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1907685&period_type=annual&limit=5"Information only, not investment advice.